M. Pierre-Yves Desbiens
Direktor/Vorstandsmitglied bei APTILON CORPORATION
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Michel Bazinet | M | 68 |
Replicor, Inc.
Replicor, Inc. Pharmaceuticals: OtherHealth Technology Replicor, Inc. operates as a biopharmaceutical company which develops and commercializes novel nucleic acid-based polymers. The company is headquartered in Montreal, Canada. | 21 Jahre |
Denis Martineau | M | 34 | 19 Jahre | |
André Brosseau | M | 62 | 19 Jahre | |
Justin Francis Beckett | M | 60 | 16 Jahre | |
Bertrand Bolduc | M | - | 6 Jahre | |
Peter Edwards | M | 62 | 4 Jahre | |
Roger Korman | M | - | 18 Jahre | |
André Charron | M | - | - | |
Paul Vander Plaetse | M | - |
VuWall Technology, Inc.
VuWall Technology, Inc. Packaged SoftwareTechnology Services VuWall Technology, Inc. provides visualization software solutions for professional applications. It offers video wall control and collaboration, AV network management, scheduling and transition management, presentation system, and video wall controllers. The company was founded by Paul Vander Plaetse in 2009 and is headquartered in Pointe-Claire, Canada. | 15 Jahre |
Gérard Antoine Limoges | M | 84 |
Replicor, Inc.
Replicor, Inc. Pharmaceuticals: OtherHealth Technology Replicor, Inc. operates as a biopharmaceutical company which develops and commercializes novel nucleic acid-based polymers. The company is headquartered in Montreal, Canada. | - |
Dennis Turpin | M | - | 3 Jahre | |
Andrew Vaillant | M | - |
Replicor, Inc.
Replicor, Inc. Pharmaceuticals: OtherHealth Technology Replicor, Inc. operates as a biopharmaceutical company which develops and commercializes novel nucleic acid-based polymers. The company is headquartered in Montreal, Canada. | - |
Moneesh Chatterjee | M | - |
Replicor, Inc.
Replicor, Inc. Pharmaceuticals: OtherHealth Technology Replicor, Inc. operates as a biopharmaceutical company which develops and commercializes novel nucleic acid-based polymers. The company is headquartered in Montreal, Canada. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Mark Benthin | M | - | 13 Jahre | |
H. Norton | M | 63 | 2 Jahre | |
Siegfried Hekimi | M | - |
Chronogen, Inc.
Chronogen, Inc. Pharmaceuticals: MajorHealth Technology Chronogen, Inc. develops drugs to treat age-dependent diseases. It manufactures drugs for neurodegenerative, cardiovascular, ischemia and reperfusion injury, and dyslipidemia diseases. The company was founded by Siegfried Hekimi in April 1998 and is headquartered in Montréal, Canada | 12 Jahre |
Yves Fouron | M | - |
Chronogen, Inc.
Chronogen, Inc. Pharmaceuticals: MajorHealth Technology Chronogen, Inc. develops drugs to treat age-dependent diseases. It manufactures drugs for neurodegenerative, cardiovascular, ischemia and reperfusion injury, and dyslipidemia diseases. The company was founded by Siegfried Hekimi in April 1998 and is headquartered in Montréal, Canada | - |
Max Fehlmann | M | - |
Chronogen, Inc.
Chronogen, Inc. Pharmaceuticals: MajorHealth Technology Chronogen, Inc. develops drugs to treat age-dependent diseases. It manufactures drugs for neurodegenerative, cardiovascular, ischemia and reperfusion injury, and dyslipidemia diseases. The company was founded by Siegfried Hekimi in April 1998 and is headquartered in Montréal, Canada | 6 Jahre |
Pascal Puchois | M | - |
Chronogen, Inc.
Chronogen, Inc. Pharmaceuticals: MajorHealth Technology Chronogen, Inc. develops drugs to treat age-dependent diseases. It manufactures drugs for neurodegenerative, cardiovascular, ischemia and reperfusion injury, and dyslipidemia diseases. The company was founded by Siegfried Hekimi in April 1998 and is headquartered in Montréal, Canada | 5 Jahre |
Nahed K. Ahmed | M | - |
Chronogen, Inc.
Chronogen, Inc. Pharmaceuticals: MajorHealth Technology Chronogen, Inc. develops drugs to treat age-dependent diseases. It manufactures drugs for neurodegenerative, cardiovascular, ischemia and reperfusion injury, and dyslipidemia diseases. The company was founded by Siegfried Hekimi in April 1998 and is headquartered in Montréal, Canada | - |
Jean-Marie Houle | M | - |
Chronogen, Inc.
Chronogen, Inc. Pharmaceuticals: MajorHealth Technology Chronogen, Inc. develops drugs to treat age-dependent diseases. It manufactures drugs for neurodegenerative, cardiovascular, ischemia and reperfusion injury, and dyslipidemia diseases. The company was founded by Siegfried Hekimi in April 1998 and is headquartered in Montréal, Canada | 4 Jahre |
Robin Hoke | F | - | 2 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Kanada | 22 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- M. Pierre-Yves Desbiens
- Persönliches Netzwerk